Real-world efficacy and safety of Ledipasvir + Sofosbuvir and Ombitasvir/Paritaprevir/Ritonavir ± Dasabuvir combination therapies for chronic hepatitis C: A Turkish experience.

Değertekin B., Demir M., Akarca U. S., Kani H. T., Üçbilek E., Yıldırım E., ...More

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, vol.31, pp.883-893, 2020 (SCI-Expanded) identifier identifier identifier


Background/Aims: This study aimed to evaluate the real-life efficacy and tolerability of direct-acting antiviral treatments for patients with chronic hepatitis C (CHC) with/without cirrhosis in the Turkish population.